Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Powles, Thomas, Park, Se Hoon, Caserta, Claudia, Valderrama, Begoña P., Gurney, Howard, Ullén, Anders, Loriot, Yohann, Sridhar, Srikala S., Sternberg, Cora N., Bellmunt, Joaquim, Aragon-Ching, Jeanny B., Wang, Jing, Huang, Bo, Laliberte, Robert J., di Pietro, Alessandra, Grivas, Petros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306435/
https://www.ncbi.nlm.nih.gov/pubmed/37071838
http://dx.doi.org/10.1200/JCO.22.01792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306435/
https://www.ncbi.nlm.nih.gov/pubmed/37071838
http://dx.doi.org/10.1200/JCO.22.01792

Ejemplares similares